HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierre-Blaise Matsiegui Selected Research

fosmidomycin

8/2006Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.
9/2005Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
11/2004Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
3/2004Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
12/2002Fosmidomycin for malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierre-Blaise Matsiegui Research Topics

Disease

15Malaria
01/2019 - 11/2002
11Falciparum Malaria (Plasmodium falciparum Malaria)
01/2016 - 03/2003
6Infections
01/2016 - 03/2004
6Body Weight (Weight, Body)
08/2006 - 03/2003
3Fever (Fevers)
12/2007 - 06/2003
2Neutropenia
08/2006 - 09/2005
1Asymptomatic Infections
10/2003
1Anemia
10/2003
1Parasitemia
10/2003
1Sickle Cell Trait
06/2003
1Cholera
11/2002
1Typhoid Fever (Typhoid)
11/2002

Drug/Important Bio-Agent (IBA)

5fosmidomycinIBA
08/2006 - 12/2002
4pyrimethamine drug combination fanasil (Fansidar)FDA Link
01/2019 - 10/2006
4Amodiaquine (Camoquin)FDA Link
01/2016 - 04/2003
3ArtesunateIBA
01/2016 - 03/2003
3Antimalarials (Antimalarial Agents)IBA
03/2011 - 03/2003
3Clindamycin (Cleocin)FDA LinkGeneric
08/2006 - 03/2004
2Mefloquine (Lariam)FDA LinkGeneric
01/2019 - 01/2015
2Lumefantrine Drug Combination Artemether (Coartem)FDA Link
01/2018 - 01/2016
2AntibodiesIBA
03/2008 - 04/2003
2Immunoglobulin G (IgG)IBA
03/2008 - 04/2003
2Quinine (Quinson)FDA Link
12/2007 - 10/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2007 - 10/2003
2Hemoglobins (Hemoglobin)IBA
08/2006 - 10/2003
2proguanil drug combination atovaquone (malarone)FDA Link
12/2003 - 11/2002
1artemisinin (artemisinine)IBA
01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
11/2015
1AntigensIBA
01/2014
1ferroquineIBA
03/2011
1EnzymesIBA
06/2008
1ImmunosorbentsIBA
06/2008
1Peptide Hydrolases (Proteases)FDA Link
06/2008
1Matrix Metalloproteinases (MMPs)IBA
06/2008
1Tissue Inhibitor of Metalloproteinase-2IBA
06/2008
1Tissue Inhibitor of Metalloproteinase-1IBA
06/2008
1interleukin-21 (interleukin 21)IBA
03/2008
1Peptides (Polypeptides)IBA
03/2008
1Malaria VaccinesIBA
03/2008
1Ibuprofen (Motrin)FDA LinkGeneric
12/2007
1Type I Tumor Necrosis Factor ReceptorsIBA
12/2007
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2007
1Type II Tumor Necrosis Factor ReceptorsIBA
12/2007
1Antiparasitic Agents (Antiparasitics)IBA
08/2006
1hemozoinIBA
09/2005
1Atovaquone (Mepron)FDA Link
12/2003
1Proguanil (Paludrine)FDA Link
12/2003
1TabletsIBA
12/2003
1CytokinesIBA
10/2003
1Interleukin-10 (Interleukin 10)IBA
10/2003
1Fas Ligand Protein (Fas Ligand)IBA
10/2003
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2003
1Merozoite Surface Protein 1 (MSA1)IBA
04/2003
1Recombinant ProteinsIBA
04/2003
1VaccinesIBA
11/2002
1Cholera VaccinesFDA Link
11/2002

Therapy/Procedure

2Therapeutics
01/2016 - 11/2015
2Chemoprevention
11/2013 - 06/2003
1Prenatal Care (Care, Prenatal)
11/2013
1Duration of Therapy
10/2006
1Combination Drug Therapy (Combination Chemotherapy)
03/2003